Also found in: Medical.
OHSSOvarian Hyperstimulation Syndrome
OHSSOvigerous-Hair Stripping Substance (biology)
OHSSOccupational Health and Safety Service (UK)
OHSSOccupational Health and Safety Staff
References in periodicals archive ?
Although OHSS may occasionally occur spontaneously between eight and twelve weeks of pregnancy or with a follicle-stimulating hormone (FSH) producing pituitary adenoma, the great majority of cases are iatrogenic due to ovulation induction in women undergoing assisted reproductive techniques (ART) (2).
One case of the LE + HMG group underwent severe OHSS, mainly manifested as hypoalbuminemia and electrolyte imbalance in the 3rd cycle.
Therefore, our study was designed to determine the impact of coasting in women at risk of developing OHSS with male factor infertility (normal women) and women with PCOS.
The secondary outcome measures consisted of the total gonadotropin dose requirements, clinical pregnancy rate, implantation rate, miscarriage rate, and the incidence of OHSS.
OHSS is self-limiting, and treatment is primarily supportive with an aim to reduce the incidence of associated complications.
We will now be doing more studies to test whether kisspeptin reduces the risk of OHSS in women who are most prone to developing it, with a view to improving the safety of IVF therapy," informed Dhillo.
Symptoms of OHSS include the following in varying degrees of severity: nausea, vomiting, diarrhea, extreme bloating, rapid weight gain, difficulty breathing etc.
Mild ovarian hyperstimulation syndrome (OHSS) is not uncommon, but severe OHSS is rare.
concluded that in patients with PCOS, who are at high risk for ovarian hyperstimulation syndrome (OHSS) and who have been stimulated with gonadotropins for in-vitro fertilisation (IVF) cycles, metformin reduces the risk of OHSS by modulating the ovarian response to the stimulation [27].
The main objectives of this webinar were to share current trends in fertility treatment with health care providers (infertility management specialists, embryologists and gynecologists) - particularly the shift to eliminate OHSS (Ovarian Hyper-stimulation Syndrome) and data to support this trend.
See Margarida Avo Santos, Ewart W Kuijk Er Nick S Macklon, "The Impact of Ovarian Stimulation for IVF on the Developing Embryo" (2010) 139 Reproduction 23 at 25; William M Buckett et al, "Obstetric Outcomes and Congenital Abnormalities After In Vitro Maturation, In Vitro Fertilization, and Intracytoplasmic Sperm Injection" (2007) 110:4 Obstetrics ET Gynecology 885 at 885; One article states that it is estimated that moderate to severe OHSS occurs in 1-10% of inductions, and that the risks of OHSS may be greater for women who are younger than 35, or who have polycystic ovarian syndrome.